摘要 |
The present invention is directed to crystal forms of the 5-HT<SUB>2C </SUB>agonist (S)-(8-(2,6-dichlorophenyl)-6-fluoro-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanamine hydrochloride, as well as compositions, processes of preparation, and uses thereof.
|